Mechanism of okadaic acid-induced neuronal death and the effect of estrogens

Journal of Neurochemistry

Volumn 108, Issue 3, 2009, Pages 732-740

  Yi, Kun Don ^a   Covey, Douglas F ^b   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Estrogen analogues; Okadaic acid; Oxidative stress; Phosphatases; Protein kinases

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 17ALPHA ESTRADIOL; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; ESTRADIOL; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID PEROXIDATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT;

ANIMALS; CASPASE 3; CASPASE 7; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CYTOSOL; ENZYME INHIBITORS; ESTROGENS; FEMALE; GLUTAMIC ACID; LIPID PEROXIDATION; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NEUROPROTECTIVE AGENTS; OKADAIC ACID; PREGNANCY; PROTEIN CARBONYLATION; RATS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 58149328523     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05805.x     Document Type: Article

References (46)

1. Arias C., Sharma N., Davies P. Shafit-Zagardo B. (1993) Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J. Neurochem. 61, 673 682.
2. Boe R., Gjertsen B. T., Vintermyr O. K., Houge G., Lanotte M. Doskeland S. O. (1991) The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 195, 237 246.
3. Butterfield D. A. (2006) Oxidative stress in neurodegenerative disorders. Antioxid. Redox Signal. 8, 1971 1973.
4. Celsi F., Svedberg M., Unger C., Cotman C. W., Carri M. T., Ottersen O. P., Nordberg A. Torp R. (2007) Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol. Dis. 26, 342 352.
5. Coyle J. T. Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689 695.
6. Fagan J. M., Sleczka B. G. Sohar I. (1999) Quantitation of oxidative damage to tissue proteins. Int. J. Biochem. Cell Biol. 31, 751 757.
7. Fernandez M. T., Zitko V., Gascon S. Novelli A. (1991) The marine toxin okadaic acid is a potent neurotoxin for cultured cerebellar neurons. Life Sci. 49, PL157 PL162.
8. Fernandez-Sanchez M. T., Garcia-Rodriguez A., Diaz-Trelles R. Novelli A. (1996) Inhibition of protein phosphatases induces IGF-1-blocked neurotrophin-insensitive neuronal apoptosis. FEBS Lett. 398, 106 112.
9. Ferri A., Nencini M., Battistini S. et al. (2004) Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients. J. Neurochem. 90, 1237 1242.
10. Gong C. X., Shaikh S., Wang J. Z., Zaidi T., Grundke-Iqbal I. Iqbal K. (1995) Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 65, 732 738.
11. Green P. S., Yang S. H., Nilsson K. R., Kumar A. S., Covey D. F. Simpkins J. W. (2001) The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology 142, 400 406.
12. Ho Y., Logue E., Callaway C. W. DeFranco D. B. (2007) Different mechanisms account for extracellular-signal regulated kinase activation in distinct brain regions following global ischemia and reperfusion. Neuroscience 145, 248 255.
13. 2. Cell. Signal. 19, 410 418.
14. Kelly M. J. Wagner E. J. (1999) Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol. Metab. 10, 369 374.
15. Kim J. Y., Yang M. S., Oh C. D., Kim K. T., Ha M. J., Kang S. S. Chun J. S. (1999) Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor. Biochem. J. 337, 275 280.
16. Kins S., Kurosinski P., Nitsch R. M. Gotz J. (2003) Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am. J. Pathol. 163, 833 843.
17. Kraft C. A., Efimova T. Eckert R. L. (2007) Activation of PKCdelta and p38delta MAPK during okadaic acid dependent keratinocyte apoptosis. Arch. Dermatol. Res. 299, 71 83.
18. Levinthal D. J. DeFranco D. B. (2004) Transient phosphatidylinositol 3-kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal-regulated kinase activation. J. Biol. Chem. 279, 11206 11213.
19. Liu R., Yang S. H., Perez E. et al. (2002) Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 33, 2485 2491.
20. Mattson M. P., Duan W., Pedersen W. A. Culmsee C. (2001) Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6, 69 81.
21. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E. Auricchio F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15, 1292 1300.
22. Myhre O., Sterri S. H., Bogen I. L. Fonnum F. (2004) Erk1/2 phosphorylation and reactive oxygen species formation via nitric oxide and Akt-1/Raf-1 crosstalk in cultured rat cerebellar granule cells exposed to the organic solvent 1,2,4-trimethylcyclohexane. Toxicol. Sci 80, 296 303.
23. Nilsen J., Chen S. Brinton R. D. (2002) Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res. 930, 216 234.
24. Pei J. J., Braak H., An W. L., Winblad B., Cowburn R. F., Iqbal K. Grundke-Iqbal I. (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res. Mol. Brain Res. 109, 45 55.
25. Pei J. J., Gong C. X., An W. L., Winblad B., Cowburn R. F., Grundke-Iqbal I. Iqbal K. (2003) Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am. J. Pathol. 163, 845 858.
26. Perez E., Liu R., Yang S. H., Cai Z. Y., Covey D. F. Simpkins J. W. (2005) Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 1038, 216 222.
27. Poppek D., Keck S., Ermak G., Jung T., Stolzing A., Ullrich O., Davies K. J. Grune T. (2006) Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem. J. 400, 511 520.
28. Rahman A., Grundke-Iqbal I. Iqbal K. (2005) Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1. Neurochem. Res. 30, 277 287.
29. Rice A. B., Ingram J. L. Bonner J. C. (2002) p38 mitogen-activated protein kinase regulates growth factor-induced mitogenesis of rat pulmonary myofibroblasts. Am. J. Respir. Cell Mol. Biol. 27, 759 765.
30. 2+ channels. Proc. Natl Acad. Sci. USA 105, 15148 15153.
31. Schmidt K. N., Traenckner E. B., Meier B. Baeuerle P. A. (1995) Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B. J. Biol. Chem. 270, 27136 27142.
32. Schonwasser D. C., Marais R. M., Marshall C. J. Parker P. J. (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18, 790 798.
33. Schreck R. Baeuerle P. A. (1994) Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol. 234, 151 163.
34. Simpkins J. W., Wang J., Wang X., Perez E., Prokai L. Dykens J. A. (2005) Mitochondria play a central role in estrogen-induced neuroprotection. Curr. Drug Targets CNS Neurol. Disord. 4, 69 83.
35. Singh M., Setalo G. Jr., Guan X., Warren M. Toran-Allerand C. D. (1999) Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19, 1179 1188.
36. Singh M., Setalo G. Jr., Guan X., Frail D. E. Toran-Allerand C. D. (2000) Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J. Neurosci. 20, 1694 1700.
37. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S. White C. L. III. (2004) Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 63, 287 301.
38. Sultana R., Perluigi M. Butterfield D. A. (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 8, 2021 2037.
39. Tunez I., Munoz Mdel C., Feijoo M., Munoz-Castaneda J. R., Bujalance I., Valdelvira M. E. Montilla Lopez P. (2003) Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain. J. Pineal Res. 34, 265 268.
40. Wang Z., Yang H., Tachado S. D., Capo-Aponte J. E., Bildin V. N., Koziel H. Reinach P. S. (2006) Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 47, 5267 5275.
41. Yi K. D. Simpkins J. W. (2008) Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology 149, 5235 5243.
42. Yi K. D., Chung J., Pang P. Simpkins J. W. (2005) Role of protein phosphatases in estrogen-mediated neuroprotection. J. Neurosci. 25, 7191 7198.
43. Yi K. D., Cai Z. Y., Covey D. F. Simpkins J. W. (2008) Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation. J. Pharmacol. Exp. Ther. 324, 1188 1195.
44. Yoon S. Y., Choi J. E., Yoon J. H., Huh J. W. Kim D. H. (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol. Dis. 22, 435 444.
45. Zhang L., Rubinow D. R., Xaing G., Li B. S., Chang Y. H., Maric D., Barker J. L. Ma W. (2001) Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12, 1919 1923.
46. Zhao L., O'Neill K. Brinton R. D. (2005) Selective estrogen receptor modulators (SERMs) for the brain: Current status and remaining challenges for developing NeuroSERMs. Brain Res. Rev. 49, 472 493.